Feedback / Questions
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Imlygic (talimogene laherparepvec) - Amgen
Tudriqev (vusolimogene oderparepvec-wtpg) - Replimune
Vusolimogene oderparepvec (Tudriqev) - an oncolytic viral therapy for melanoma.
(PubMed, Med Lett Drugs Ther)
-
Oct 6, 2026 -
No abstract available
Journal
•
Melanoma • Oncology • Solid Tumor
http://www.ncbi.nlm.nih.gov/pubmed/42832393
Oct 6, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next